StockNews.com assumed coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a research report report published on Thursday. The firm issued a sell rating on the stock.
Ayala Pharmaceuticals Price Performance
Shares of ADXS opened at $0.03 on Thursday. The stock has a 50-day moving average of $0.03 and a 200-day moving average of $0.21. The company has a market cap of $1.15 million, a PE ratio of 0.00 and a beta of 1.72. Ayala Pharmaceuticals has a one year low of $0.00 and a one year high of $1.49.
About Ayala Pharmaceuticals
Recommended Stories
- Five stocks we like better than Ayala Pharmaceuticals
- Consumer Discretionary Stocks Explained
- Is Spotify Stock Poised to Soar? Options Traders Think So
- Ride Out The Recession With These Dividend Kings
- Misses and Beats: 3 Stocks That Are Moving Markets Right Now
- ETF Screener: Uses and Step-by-Step Guide
- Cisco on the Rise: AI Potential and Analyst Upgrades Drive Gains
Receive News & Ratings for Ayala Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ayala Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.